Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 6, Number 2—April 2000

Research

Vibrio cholerae O139 in Calcutta, 1992-1998: Incidence, Antibiograms, and Genotypes

Arnab Basu*, Pallavi Garg*, Simanti Datta*, Soumen Chakraborty*, Tanuja Bhattacharya*, Asis Khan*, T. Ramamurthy*, S.K. Bhattacharya*, Shinji Yamasaki†, Yoshifumi Takeda‡, and G. Balakrish Nair*Comments to Author 
Author affiliations: *National Institute of Cholera and Enteric Diseases, Calcutta, India; †International Medical Center of Japan, Tokyo, Japan; and ‡National Institute of Infectious Diseases, Tokyo, Japan

Main Article

Figure 3

Antibiotic resistance pattern of the V. cholerae O139 strains. Abbreviations: A, ampicillin; C, chloramphenicol; Cf, ciprofloxacin; Co, cotrimoxazole; Fz, furazolidone; G, gentamycin; N, neomycin; Na, nalidixic acid; Nx, norfloxacin; S, streptomycin; T, tetracycline.

Figure 3. Antibiotic resistance pattern of the V. cholerae O139 strains. Abbreviations: A, ampicillin; C, chloramphenicol; Cf, ciprofloxacin; Co, cotrimoxazole; Fz, furazolidone; G, gentamycin; N, neomycin; Na, nalidixic acid; Nx, norfloxacin; S, streptomycin; T, tetracycline.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO